Clinical Trial Update: Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing an immunosuppressive regimen including everolimus with reduced cyclosporine versus mycophenolic acid with standard-dose cyclosporine i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Kidney Transplantation

Drugs mentioned

• Cyclosporine A (cyclosporine)
• Everolimus (everolimus)
• Mycophenolic acid (mycophenolic acid)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Transplantation Infection, Cytomegalovirus Infection | Phase 4 | Status: COMPLETED